MediWound (FRA:M8W) Cash Flow from Discontinued Operations : €0.00 Mil (TTM As of Mar. 2025)

View and export this data going back to 2014. Start your Free Trial

What is MediWound Cash Flow from Discontinued Operations?

Cash flow from discontinued operations is the cash received by a company that comes from the sale of part of business.

MediWound's cash flow from discontinued operations for the three months ended in Mar. 2025 was €0.00 Mil. It means MediWound received €0.00 Mil from the sale of part of business quarterly. MediWound's cash flow from discontinued operations for the trailing twelve months (TTM) ended in Mar. 2025 was €0.00 Mil.

MediWound Cash Flow from Discontinued Operations Historical Data

The historical data trend for MediWound's Cash Flow from Discontinued Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MediWound Cash Flow from Discontinued Operations Chart

MediWound Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Cash Flow from Discontinued Operations

Get a 7-Day Free Trial

MediWound Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Cash Flow from Discontinued Operations	Get a 7-Day Free Trial															-	-	-	-	-

MediWound Cash Flow from Discontinued Operations Calculation

Cash received by a company that comes from the sale of part of business.

Cash Flow from Discontinued Operations for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

MediWound Cash Flow from Discontinued Operations Related Terms

Thank you for viewing the detailed overview of MediWound's Cash Flow from Discontinued Operations provided by GuruFocus.com. Please click on the following links to see related term pages.

MediWound Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MediWound Ltd (FRA:M8W) » Definitions » Cash Flow from Discontinued Operations

Comparable Companies

Traded in Other Exchanges

MDWD:USA

Address

42 Hayarkon Street, Yavne, ISR, 8122745

Website

https://www.mediwound.com

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

MediWound Headlines

No Headlines